A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

Also called NCT05355948

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,000 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05355948
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05355948. Randomized; no masking; primary purpose prevention. Start 2022-05-09 (actual); primary completion 2023-07-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke
Acronym
MEMO-DAF8
Condition
Atrial Fibrillation/Flutter in Patients With High Risk of Stroke
Intervention (Device)
MEMO Patch PLUS for 1 day
Intervention (Device)
MEMO Patch PLUS for More than 8-days
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct05355948
Content hash
4ad180f7ff41aab3eff94b3892b68b6a8018a18b29c89a960a1010ea0e474286